| Gene Symbol | PARVALBUMIN |
| Aliases | PARVALBUMINPROTEIN |
| Target Class | Signaling Protein |
| Mechanism of Action | No known druggable mechanism |
| Druggability | Low (0.34) |
| Clinical Stage | Phase II |
| Molecular Weight | ~11.5 kDa |
| GeneCards | PARVALBUMIN |
| Human Protein Atlas | PARVALBUMIN |
| Associated Diseases | ALS, AUTISM, Aging, Alzheimer, Alzheimer'S Disease |
| Known Drugs/Compounds | 17-β estradiol |
| Interactions | NR3C1, FKBP5, TAU, SST, PENK, TRKB |
| SciDEX Target | View Target Profile (3 clinical trials) |
| SciDEX Hypotheses | Closed-loop transcranial focused ultrasound to res Closed-loop transcranial focused ultrasound with 4 Closed-loop tACS targeting EC-II PV interneurons t (+9 more) |
| KG Connections | 637 knowledge graph edges |
| Databases | GeneCardsUniProtNCBI GeneHPASTRING |